Lupitas Pharmaceuticals Private Limited, a active private limited company, was established on 31 March 2014 in Surat, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100GJ2014PTC079490. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.70 M.
It upholds a compliant status. Employing 9 professional, Its leadership includes Ghanshyam Parsottambhai Laheri (Director), Pravinbhai Govindbhai Vekariya (Director), Hetalben Dipakbhai Bhadiyadara (Director). Past directors included Dipal Paresh Dhameliya, Sheetal Mukeshkumar Padsala, Ashaben Hareshbhai Intaliya. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 33, Swaminarayan Nagar-1, Near Kalakunj, Varachha Road,, Surat, Gujarat, 395006.
U24100GJ2014PTC079490
079490
31 March 2014
₹1.00 M
₹0.70 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Lupitas Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ghanshyam Parsottambhai Laheri | Director | 31 Mar 2014 | Current |
| Pravinbhai Govindbhai Vekariya | Director | 31 Mar 2014 | Current |
| Hetalben Dipakbhai Bhadiyadara | Director | 12 Jun 2015 | Current |
| Kishorkumar Maganbhai Kachhadiya | Director | 12 Jun 2015 | Current |
| Ashish Rameshchandra Pandya | Director | 18 Sep 2015 | Current |
| Pareshkumar Ramjibhai Dhameliya | Director | 04 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Feb 2022 | Past |
| Pramod Abcsdd | Director | 01 Feb 2022 | Past |
| Pramod Abcsdd | Director | 01 Feb 2022 | Past |
| Pramod Abcsdd | Director | 01 Feb 2022 | Past |
| Pramod Abcsdd | Additional Director | 02 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 02 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lupitas Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.94% decrease. The company also saw a substantial improvement in profitability, with a 236.24% increase in profit. The company's net worth moved up by a moderate rise of 4.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Lupitas Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Lupitas Pharmaceuticals has a workforce of 9 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Lupitas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lupitas Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Lupitas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Lupitas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
The activity Pareshkumar Ramjibhai Dhameliya was appointed as a Director was appointed as a Director on 04 Aug 2021 & has been associated with this company since 4 years 5 months . was completed.
The activity Ashish Rameshchandra Pandya was appointed as a Director was appointed as a Director on 18 Sep 2015 & has been associated with this company since 10 years 3 months . was completed.
The activity Hetalben Dipakbhai Bhadiyadara was appointed as a Director was appointed as a Director on 12 Jun 2015 & has been associated with this company since 10 years 7 months . was completed.
Kishorkumar Maganbhai Kachhadiya was appointed as a Director was appointed as a Director on 12 Jun 2015 & has been associated with this company since 10 years 7 months . was recorded as a recent event.
The CIN of Lupitas Pharmaceuticals Private Limited is U24100GJ2014PTC079490.
Lupitas Pharmaceuticals Private Limited is headquartered at 33, Swaminarayan Nagar-1, Near Kalakunj, Varachha Road,, Surat, Gujarat, 395006.
Lupitas Pharmaceuticals Private Limited was incorporated on 31 March 2014.
The current directors of Lupitas Pharmaceuticals Private Limited are
The primary industry of Lupitas Pharmaceuticals Private Limited is Trade.
Lupitas Pharmaceuticals Private Limited is unlisted.
The authorized capital of Lupitas Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.70 M.
The compliance status of Lupitas Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX